This topic focuses on the comparative effectiveness and safety of the drugs for preventing migraine attacks in children and adults. Separate research reviews were conducted for these two populations. The published protocol and the full reports and executive summaries can be accessed on the right navigation of this Web page.
Archived: These reports are greater than 3 years old. Findings may be used for research purposes, but should not be considered current.